Casi Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Casi pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Casi Pharmaceuticals Today - Breaking & Trending Today

CASI Pharmaceuticals (NASDAQ:CASI) Given New $6.00 Price Target at HC Wainwright

CASI Pharmaceuticals (NASDAQ:CASI – Free Report) had its price target reduced by HC Wainwright from $12.00 to $6.00 in a research report report published on Wednesday, Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for CASI Pharmaceuticals’ Q2 2024 earnings at ($0.63) EPS, Q3 2024 […] ....

United States , Pharmaceuticals Inc , Pharmaceuticals Company Profile , Casi Pharmaceuticals , Pharmaceuticals Daily , Howland Capital Management , Pharmaceuticals Stock Performance , Free Report , Get Free Report , Capital Management ,

CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance Shares of CASI Pharmaceuticals stock opened at $3.11 on Friday. CASI Pharmaceuticals has a one year low of $1.85 and […] ....

United States , Pharmaceuticals Inc , Virtu Financial , Pharmaceuticals Daily , Pharmaceuticals Stock Performance , Susquehanna International Group , Citigroup Inc , Renaissance Technologies , Pharmaceuticals Company Profile , Free Report , International Group , Get Free Report , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on CASI Pharmaceuticals (NASDAQ:CASI)

StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance NASDAQ CASI opened at $3.61 on Thursday. CASI Pharmaceuticals has a fifty-two week low of $1.85 and a fifty-two week […] ....

United States , Renaissance Technologies , Susquehanna International Group , Pharmaceuticals Daily , Citigroup Inc , Pharmaceuticals Stock Performance , Pharmaceuticals Inc , Virtu Financial , Free Report , Get Free Report , International Group , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,

StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI)

StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright increased their price target on CASI Pharmaceuticals from $10.00 to $12.00 and gave the stock a buy rating in a […] ....

United States , Virtu Financial , Pharmaceuticals Trading Down , Susquehanna International Group , Renaissance Technologies , Pharmaceuticals Company Profile , Pharmaceuticals Daily , Pharmaceuticals Inc , Citigroup Inc , Free Report , Trading Down , International Group , Get Free Report , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,

CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note published on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright raised their price objective on shares of CASI Pharmaceuticals from $10.00 to $12.00 and gave the company a buy rating in […] ....

United States , Renaissance Technologies , Pharmaceuticals Daily , Pharmaceuticals Inc , Pharmaceuticals Price Performance , Citigroup Inc , Virtu Financial , Susquehanna International Group , Free Report , International Group , Get Free Report , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,